E47: From Research to Relief Tackling Long COVID Symptoms with Keith Ellis, PhD. episode artwork

EPISODE · Jan 9, 2025 · 49 MIN

E47: From Research to Relief Tackling Long COVID Symptoms with Keith Ellis, PhD.

from Longevity Unlocked · host Dr. K and Coach Kyle

Summary In this episode of the Peak Performance Podcast, Coach Kyle and Dr. Keith Ellis, a medicinal chemist, discuss the complexities of long COVID, exploring its symptoms, potential treatments, and the challenges faced in defining and diagnosing the condition. Dr. Ellis shares his background in medicinal chemistry and his shift towards researching long COVID due to the lack of effective solutions available for those suffering from lingering symptoms post-COVID infection. The conversation highlights the importance of understanding the underlying mechanisms of long COVID and the need for targeted drug discovery.   Key Takeaways Background of Dr. Keith Ellis: A medicinal chemist with experience in drug discovery, Dr. Ellis emphasizes the significance of early-stage research in developing effective treatments. Definition Challenges: Long COVID lacks a clear definition, making diagnosis difficult; symptoms can vary widely among individuals. Research Landscape: There is a wealth of literature on long COVID, but it often lacks focus on practical solutions for symptom alleviation. Potential Misdiagnosis: Some cases of long COVID may be misdiagnosed as other conditions, such as reactivated Epstein-Barr virus. Symptom Management vs. Treatment: The podcast discusses the difference between managing symptoms and treating underlying causes, emphasizing the need for more targeted approaches. Chapters   00:00 Introduction 00:54 Innovative Approaches to Long COVID: Insights from Dr. Keith Ellis 03:11 The Molecular Foundations of Drug Discovery 06:03 The Art of Early Discovery and Lead Validation 08:03 Dr. Ellis's Background and Transition to Long COVID Research 10:12 Turning Long COVID Research into Real Solutions 11:40 Defining the Undefined in Post-COVID Symptoms 13:20 Tackling Complex Post-Viral Syndromes Through Molecular Discovery 21:30 The Microclots Hypothesis Explained 22:46 Microclots and Their Impact: How Viral Proteins Disrupt the Body’s Systems 26:22 Methylene Blue: A Low-Cost Solution for Oxygenation and Amyloid Plaque Treatment? 29:54 Exploring Methylene Blue and Microclots 32:48 A Step Back to Solve Long COVID and the Role of EBOO and Apheresis 35:27 A Safer, Accessible Solution for Microclot Breakdown 43:52 nnovative Approaches for Viral Load Reduction and Microclot Management 45:46 Dr. Keith Ellis Discusses CircuGuard and Accessible Solutions for Better Health Sponsors: This episode is sponsored by The Longevity Center FL. Your one stop natural medicine shop. The LCFL is the perfect blend of Integrative, Osteopathic and Regenerative Health Care in West Palm Beach, FL.  Website: https://www.thelcfl.com/  Instagram: https://www.instagram.com/thelcfl.com    Dr. Keith Ellis: https://keithcellisphd.com/  People: Website: https://peakperformancepodcast.online/ On Instagram: @thepeakperformancepod On X: @PeakPerformPod Dr. K On Instagram @theosteodoc Coach Kyle On Instagram @toxinfreekyle

Episode metadata supplied by the publisher feed · Published Jan 9, 2025

Embed this episode

NOW PLAYING

E47: From Research to Relief Tackling Long COVID Symptoms with Keith Ellis, PhD.

0:00 49:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Longevity Unlocked?

This episode is 49 minutes long.

When was this Longevity Unlocked episode published?

This episode was published on January 9, 2025.

Can I download this Longevity Unlocked episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!